Continuous haemofiltration in the intensive care unit

Critical Care

Volumn 4, Issue 6, 2000, Pages 339-345

  Bellomo, Rinaldo ^a   Ronco, Claudio ^b  

^a AUSTIN HEALTH   (Australia)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Acute renal failure; Blood purification; Continuous renal replacement therapy; Cytokines; Haemodialysis; Haemofiltration; Multiorgan failure syndrome; Sepsis; Septic shock

Indexed keywords

DIURETIC AGENT; HEPARIN;

COST BENEFIT ANALYSIS; CRITICAL ILLNESS; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE; MORTALITY; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; TECHNOLOGY; TREATMENT INDICATION;

BRAIN EDEMA; CRITICAL ILLNESS; DIFFUSION OF INNOVATION; HEART FAILURE, CONGESTIVE; HEMOFILTRATION; HUMANS; INTENSIVE CARE; KIDNEY FAILURE; LIVER FAILURE; PATIENT SELECTION; SHOCK, SEPTIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0033638874     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc718     Document Type: Review

References (54)

1. Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics
2. History and development of continuous renal replacement techniques
3. Continuous renal replacement therapy and the failing kidney
4. Comparison of pumpdriven and spontaneous continuous hemofiltration in postoperative acute renal failure
5. Continuous versus intermittent renal replacement therapy in the intensive care unit
6. Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients
7. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig
8. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous veno-venous hemodiafiltration in critically ill patients
9. Vascular access for continuous renal replacement therapy
10. Circulation of the continuous artificial kidney: Blood flow, pressures, clearances and the search for the best
11. Principles of solute clearance during continuous renal replacement therapy
12. Current technology for continuous renal replacement therapies
13. Nomenclature for continuous renal replacement therapies
14. Preliminary experience with high-volume hemofiltration in human septic shock
15. Continuous plasma filtration coupled with absorbents
16. Quo vadis CRRT?
17. Hemofiltration during cardiopulmonary bypass
18. Intradialytic renal hemodynamics: Potential consequences for the management of the patient with acute renal failure
19. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure
20. Renal replacement therapy in acute renal failure: Solute removal, mechanisms and dose quantification
21. Acute renal failure in the intensive care unit: Adequacy of dialysis and the case for continuous therapies
22. Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure
23. Dose of intermittent hemodialysis and outcome of acute renal failure: A prospective randomized study
24. Severe acute renal failure: A comparison of acute continuous hemodiafiltration and conventional dialytic therapy
25. Energy expenditure in the acute renal failure patient mechanically ventilated
26. Nutritional effect of continuous hemodiafiltration
27. Continuous arteriovenous haemodiafiltration in the critically ill: Influence on major nutrient balances
28. The nutritional management of acute renal failure in the intensive care unit
29. Management of patients with acute renal failure complicated by cerebral edema
30. Effect of renal replacement therapy on patients with combined acute renal failure and fulminant hepatic failure
31. Changes in circulating norepinephrine with hemofiltration in advanced congestive cardiac failure
32. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients
33. Isolation of myocardial depressant factor (s) from the ultrafiltrate of heart failure patients with acute renal failure
34. Continuous hemofiltration as blood purification in sepsis
35. Removal and generation of inflammatory mediators during continuous renal replacement therapies
36. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine
37. Continuous plasma filtration coupled with sorbents
38. High-volume hemofiltration improves hemodynamics of endotoxin induced shock in the pig
39. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late
40. Does continuous hemodiafiltration improve survival in patients with critical illness and associated acute renal failure?
41. Continuous versus intermittent dialysis for acute renal failure in the ICU: Results from a randomized multicenter trial
42. CRRT in the area of cost containment: Is it justified?
43. Outcome studies of continuous renal replacement therapy in the intensive care
44. Anticoagulant regimens in acute continuous hemodiafiltration: A comparative study
45. Anticoagulation for continuous renal replacement therapies
46. Continuous arteriovenous hemofiltration in acute renal failure
47. Who should manage continuous renal replacement therapy in the intensive care unit? The intensivist's viewpoint
48. The rising era of critical care nephrology
49. Should continuous renal replacement therapy be used for 'non renal' indications in critically ill patients with shock? A review
50. Continuous hemofiltration in severe sepsis: Is it beneficial?
51. Mediator removal with CRRT: Complement and cytokines
52. Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense
53. Daily 12-hour sustained low-efficiency hemodialysis (SLED) for the treatment of critically ill patients with acute renal failure: Initial experience